Key result
Medication reviews in dementia lack studies evaluating medication adherence, quality of life, and mortality.
Why the study?
Persons with dementia face challenges related to polypharmacy and inappropriate medication use, but the benefit of regular medication reviews on clinical outcomes has not been examined in this population.
Do medication reviews improve clinical outcomes in older adults with dementia?
Do medication reviews improve clinical outcomes in older adults with dementia?
This scoping review highlights significant gaps in the literature regarding the impact of medication reviews on medication adherence, quality of life, and mortality in older adults with dementia.
Answers are grounded in this paper and cite their sources.
Evidence gaps preclude recommending medication reviews in dementia; leaves open their clinical value.
Persons diagnosed with dementia are often faced with challenges related to polypharmacy and inappropriate medication use and could benefit from regular medication reviews. However, the benefit of such reviews has not been examined in this population. Therefore, the current scoping review was designed to identify the gaps in the current knowledge regarding the impact of medication reviews on the clinical outcomes in older adults with dementia. Relevant studies were identified by searching three databases (Ovid MEDLINE, Ovid EMBASE, and Scopus) from inception to January 2022 with a combination of keywords and medical subject headings. After the removal of duplicates and ineligible articles, 22 publications of the initial 8346 were included in this review. A total of 57 outcomes were identified, including those pertaining to the evaluation of medication use (n = 17), drug-related interventions (n = 11), drug-related problems (n = 10), dementia-related behavioral symptoms (n = 8), cost-effectiveness (n = 2), drug-related hospital admissions (n = 1), as well as outcomes classified as other (n = 7). Gaps identified through this scoping review included the paucity of studies measuring the impact of medication reviews on the medication management capacity and medication adherence, quality of life, and mortality.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2023) conducted a review in Dementia (n=22). Medication reviews was evaluated on Clinical outcomes including evaluation of medication use, drug-related interventions, and drug-related problems. A scoping review of 22 publications identified 57 outcomes related to medication reviews in dementia, highlighting a lack of studies on medication adherence, quality of life, and mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: